eGenesis

Company that develops effective human transplantable organs, tissues and cells.

eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis has the capability to solve the global organ crisis by providing an alternative to allotransplantation.

Visit website: https://www.egenesisbio.com/

 egenesisbio

 eGenesisBio

Details last updated 11-Dec-2019

eGenesis News

Egenesis raises $191m to bring genetically edited pig organs to human trials

Egenesis raises $191m to bring genetically edited pig organs to human trials

Longevity Technology - 05-Sep-2024

Xenotransplantation biotech advances groundbreaking pig kidney transplants

Scientists remove retroviral DNA from pig's genetic code

Scientists remove retroviral DNA from pig's genetic code

Independent - 10-Aug-2017

Possible to breed pigs to harvest their organs to meet the demand for new tissue

Topics mentioned on this page:
Gene Therapy, Stem Cells